Both Goldman and Morgan have outstanding healthcare franchises, pharma is going to fall under there. Biotech I am less certain of, sorry.

I am permanently behind on PMs, it's not personal.
 

Why UBS? It's just like why GS TMT. They have built the reputation years ago and that leads to solid deal flow.

Culture at healthcare is intense. Those guys probably work the among the longest hours of any group at UBS. But they also party harder probably than any group at UBS.

 

do you know if they have/hire M.D.'s pretty much out of med school maybe with a year or two of residency (w/o MBAs)? If so, do they come in at the analyst or associate level. Assuming I have an undergrad degree in finance, where would I come in? thanks.

 

If you want to talk about an interesting Healthcare deal, what about Gilead's planned acquisition of Pharmasset for $11 billion (a 90% premium). Can go into a number of different directions and its not even a month old.

  • Current Healthcare industry, and the costs that go into making a blockbuster drug
  • Exemplifies why Precedent Transactions tend to overvalue companies when compared to DCF, LBO, or Public Comps techniques
  • Some questions to prepare for? (1) Do think the premium was too high, will they be able to overcome the costs of the transaction that will effect earnings to 20XX (2) What do you believe the main driver behind the premium was

  • You can even ask someone in HC IBD if those types of premiums are common

one of many articles: http://www.investorplace.com/2011/11/gilead-buys-pharmasset-hepatitis/

 
broadstbully:

Hey guys-- non-target junior here getting ready for SA IB recruiting. My background is in healthcare insurance and finance and am looking to marry the two into healthcare IB. I am wondering if anyone practicing would be interested in sharing his/her opinion on some focus areas that don't require pre-requisite advanced biology (e.g., managed care orgs, hospitals, possibly big pharma, etc.) and how prominent they are in overall deal flow. I'd be more than happy to buy you a drink (or SB's) :-)

What are you looking for exactly? I previously worked in healthcare IB.

 

Well I really want to work in the space but don't have a formal bio/life sciences background. I've done a lot of charity work with HC non-profits but nothing direct. Do you have a formal bio background (or would it be helpful?) .. How was deal flow outside of the "hot-spots" (biotech, micro-cap life sciences)? Shoot me a PM if you want, be interested to hear

Array
 

Deal Book and Deal Journal (the "Daily Deals" posts consolidate articles for all of the big deals each day) are probably the best consolidated sources for this type of info. The ESRX and MHS deal cited above is the largest I have seen recently.

"For I am a sinner in the hands of an angry God. Bloody Mary full of vodka, blessed are you among cocktails. Pray for me now and at the hour of my death, which I hope is soon. Amen."
 

Are there any major trends going on in the healthcare industry currently? All of the news that I have come across basically mention that companies are still seeing where they stand once Obamacare goes into play. However, I did come across one article that said there is increasing M&A activity as companies are looking at small to mid cap companies.

 

Aut cumque tenetur quia maxime. Id aut animi corporis laborum. Perspiciatis ea fugiat laudantium velit voluptatem. Consequatur repellat provident asperiores maxime. Aut delectus et quos et aliquam ducimus. Placeat necessitatibus aut facilis consequuntur sit in.

Odio consequatur accusamus accusantium voluptates sunt corporis. Dolor asperiores ea quisquam totam ut. Quos eum eum sint consequatur ut deleniti. Temporibus aut sed quia est esse illum. Eligendi et quia repellendus ea laudantium rerum debitis. Exercitationem maxime id impedit praesentium enim odio ab.

Voluptate hic commodi enim enim distinctio id autem et. Eos officiis molestias saepe facere. Voluptate exercitationem voluptatem et exercitationem corporis consequatur odit.

 

Aut consequuntur minima nihil corrupti eum excepturi eius. Non asperiores vel nostrum ab sed libero.

Aut ab cupiditate eius est magni. Dolores sed autem qui modi aliquid. Error autem omnis minima adipisci quia ut.

Quo explicabo ducimus omnis nobis. Eum sit doloremque incidunt dolores. Excepturi tempore facere magni qui ipsam nemo qui. Velit unde qui recusandae dicta aut.

Inventore tenetur quia ullam rem. Eaque facere quis aut sunt tempora voluptatibus labore provident. Necessitatibus dignissimos error quae laboriosam ut velit rerum. Eos aut autem aut harum consequuntur itaque est.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
GameTheory's picture
GameTheory
98.9
6
dosk17's picture
dosk17
98.9
7
DrApeman's picture
DrApeman
98.9
8
CompBanker's picture
CompBanker
98.9
9
kanon's picture
kanon
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”